Bone marrow‐derived mesenchymal stem cells enhance autophagy via PI3K/AKT signalling to reduce the severity of ischaemia/reperfusion‐induced lung injury
Open Access
- 14 July 2015
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 19 (10) , 2341-2351
Abstract
Autophagy, a type II programmed cell death, is essential for cell survival under stress, e.g. lung injury, and bone marrow‐derived mesenchymal stem cells (BM‐MSCs) have great potential for cell therapy. However, the mechanisms underlying the BM‐MSC activation of autophagy to provide a therapeutic effect in ischaemia/reperfusion‐induced lung injury (IRI) remain unclear. Thus, we investigate the activation of autophagy in IRI following transplantation with BM‐MSCs. Seventy mice were pre‐treated with BM‐MSCs before they underwent lung IRI surgery in vivo. Human pulmonary micro‐vascular endothelial cells (HPMVECs) were pre‐conditioned with BM‐MSCs by oxygen‐glucose deprivation/reoxygenation (OGD) in vitro. Expression markers for autophagy and the phosphoinositide 3‐kinase/protein kinase B (PI3K/Akt) signalling pathway were analysed. In IRI‐treated mice, administration of BM‐MSCs significantly attenuated lung injury and inflammation, and increased the level of autophagy. In OGD‐treated HPMVECs, co‐culture with BM‐MSCs attenuated endothelial permeability by decreasing the level of cell death and enhanced autophagic activation. Moreover, administration of BM‐MSCs decreased the level of PI3K class I and p‐Akt while the expression of PI3K class III was increased. Finally, BM‐MSCs‐induced autophagic activity was prevented using the inhibitor LY294002. Administration of BM‐MSCs attenuated lung injury by improving the autophagy level via the PI3K/Akt signalling pathway. These findings provide further understanding of the mechanisms related to BM‐MSCs and will help to develop new cell‐based therapeutic strategies in lung injury.Keywords
Funding Information
- National Natural Science Foundation of China (81490533, 81200051)
This publication has 30 references indexed in Scilit:
- Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?Journal of Cellular and Molecular Medicine, 2013
- Autophagic Protein LC3B Confers Resistance against Hypoxia-induced Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2011
- TGF-β1 Protects against Mesangial Cell Apoptosis via Induction of AutophagyJournal of Biological Chemistry, 2010
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Effects of curcumin or dexamethasone on lung ischaemia–reperfusion injury in ratsEuropean Respiratory Journal, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- Mesenchymal stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in miceThe Journal of Pathology, 2007
- Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesisNature Cell Biology, 2007
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- Autophagy: dual roles in life and death?Nature Reviews Molecular Cell Biology, 2005